dronabinol has been researched along with Central Nervous System Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chisari, CG; Fernández, Ó; Ferrer-Picón, E; Hernández Vicente, F; Patti, F; Sarroca, J; Vila Silván, C | 1 |
| Bourdel, MC; Dervaux, A; Krebs, MO; Laqueille, X | 1 |
| Andreasen, MF; Birkler, RI; Charles, AV; Ingemann-Hansen, O; Johannsen, M; Telving, R | 1 |
| Nurmikko, TJ; Rog, DJ; Young, CA | 1 |
| Colasanti, BK; Craig, CR; Powell, SR | 1 |
1 trial(s) available for dronabinol and Central Nervous System Diseases
| Article | Year |
|---|---|
Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Topics: Administration, Oral; Administration, Sublingual; Adult; Aerosols; Analgesics, Opioid; Cannabidiol; Central Nervous System Diseases; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Mucosa; Multiple Sclerosis; Pain; Plant Extracts | 2007 |
4 other study(ies) available for dronabinol and Central Nervous System Diseases
| Article | Year |
|---|---|
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome'.
Topics: Cannabidiol; Central Nervous System Diseases; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Cramp; Muscle Spasticity; Pain; Spasm; Treatment Outcome | 2022 |
Neurological soft signs in non-psychotic patients with cannabis dependence.
Topics: Adolescent; Adult; Age of Onset; Analysis of Variance; Cannabinoid Receptor Agonists; Case-Control Studies; Central Nervous System Diseases; Cerebellum; Dronabinol; Female; Humans; Interview, Psychological; Male; Marijuana Abuse; Neurologic Examination; Neuropsychological Tests; Paris; Psychomotor Performance; Receptors, Cannabinoid; Schizophrenia; Substance Abuse Treatment Centers; Young Adult | 2013 |
Screening analysis for medicinal drugs and drugs of abuse in whole blood using ultra-performance liquid chromatography time-of-flight mass spectrometry (UPLC-TOF-MS)--toxicological findings in cases of alleged sexual assault.
Topics: Adolescent; Adult; Benzodiazepines; Central Nervous System Diseases; Chromatography, Liquid; Crime Victims; Dronabinol; Ethanol; Forensic Toxicology; Humans; Hypnotics and Sedatives; Illicit Drugs; Mass Spectrometry; Middle Aged; Pharmaceutical Preparations; Phenobarbital; Rape; Substance Abuse Detection; Young Adult | 2012 |
Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta 9-tetrahydrocannabinol or cannabichromene.
Topics: Action Potentials; Animals; Cannabinoids; Cats; Central Nervous System Diseases; Conjunctiva; Cornea; Dose-Response Relationship, Drug; Dronabinol; Electroencephalography; Electromyography; Eye Diseases; Female; Intraocular Pressure; Male; Rats; Rats, Inbred Strains; Sleep | 1984 |